{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:33Z","timestamp":1792783413084,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)","id":[{"id":"https:\/\/ror.org\/01zgy1s35","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["PharmacoEconomics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s40273-026-01640-1","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:51:25Z","timestamp":1783947085000},"page":"1225-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endovascular Treatment for Acute Ischemic Stroke: A Methodological Systematic Review of Health Economic Decision Modeling Studies"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1369-7253","authenticated-orcid":false,"given":"Andreas","family":"Beisel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5711-6862","authenticated-orcid":false,"given":"Hans-Helmut","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-434X","authenticated-orcid":false,"given":"Judith","family":"Dams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"10","key":"1640_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBD 2019 Stroke Collaborators","year":"2021","unstructured":"GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795\u2013820.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1640_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/CRD.0000000000000663","volume":"32","author":"K Jan","year":"2024","unstructured":"Jan K, Chong JY. Treatment of acute ischemic stroke: the last 30 years of trials and tribulations. Cardiol Rev. 2024;32(3):203\u201316.","journal-title":"Cardiol Rev"},{"key":"1640_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijerph18147552","volume":"18","author":"TN Rochmah","year":"2021","unstructured":"Rochmah TN, Rahmawati IT, Dahlui M, Budiarto W, Bilqis N. Economic burden of stroke disease: a systematic review. Int J Environ Res Public Health. 2021;18:14.","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"1640_CR4","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1161\/STROKEAHA.119.023811","volume":"50","author":"RG Nogueira","year":"2019","unstructured":"Nogueira RG, Rib\u00f3 M. Endovascular treatment of acute stroke. Stroke. 2019;50(9):2612\u20138.","journal-title":"Stroke"},{"issue":"4","key":"1640_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamaneurol.2024.0190","volume":"81","author":"D Renedo","year":"2024","unstructured":"Renedo D, Acosta JN, Leasure AC, Sharma R, Krumholz HM, de Havenon A, et al. Burden of ischemic and hemorrhagic stroke across the US from 1990 to 2019. JAMA Neurol. 2024;81(4):394\u2013404.","journal-title":"JAMA Neurol"},{"issue":"9","key":"1640_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.mpmed.2020.06.002","volume":"48","author":"SJ Murphy","year":"2020","unstructured":"Murphy SJ, Werring DJ. Stroke: causes and clinical features. Medicine. 2020;48(9):561\u20136.","journal-title":"Medicine"},{"issue":"10029","key":"1640_CR7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;387(10029):1723\u201331.","journal-title":"Lancet"},{"issue":"2","key":"1640_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3174\/ajnr.A2329","volume":"32","author":"MN Nguyen-Huynh","year":"2011","unstructured":"Nguyen-Huynh MN, Johnston SC. Is mechanical clot removal or disruption a cost-effective treatment for acute stroke? AJNR Am J Neuroradiol. 2011;32(2):244\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"14","key":"1640_CR9","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJMoa2213379","volume":"388","author":"X Huo","year":"2023","unstructured":"Huo X, Ma G, Tong X, Zhang X, Pan Y, Nguyen TN, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med. 2023;388(14):1272\u201383.","journal-title":"N Engl J Med"},{"issue":"11","key":"1640_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107906","volume":"33","author":"A Mart\u00edn-Guti\u00e9rrez","year":"2024","unstructured":"Mart\u00edn-Guti\u00e9rrez A, Leal-Vega L, Coco-Mart\u00edn MB, Arenillas-Lara JF. A systematic review of the socioeconomic impact of mechanical thrombectomy for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2024;33(11):107906.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"1640_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s40273-023-01289-0","volume":"41","author":"J Dams","year":"2023","unstructured":"Dams J, Zapp J-J, K\u00f6nig H-H. Modelling the cost effectiveness of treatments for Parkinson\u2019s disease: an updated methodological review. Pharmacoeconomics. 2023;41(10):1205\u201328.","journal-title":"Pharmacoeconomics"},{"issue":"7","key":"1640_CR12","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","volume":"48","author":"JP Broderick","year":"2017","unstructured":"Broderick JP, Adeoye O, Elm J. Evolution of the Modified Rankin Scale and its use in future stroke trials. Stroke. 2017;48(7):2007\u201312.","journal-title":"Stroke"},{"issue":"5","key":"1640_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u20137.","journal-title":"Stroke"},{"key":"1640_CR14","unstructured":"EuroQol. EQ-5D-5L. https:\/\/euroqol.org\/information-and-support\/euroqol-instruments\/eq-5d-5l\/. Accessed 8 Oct 2025."},{"issue":"1","key":"1640_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1524-4733.2005.03065.x","volume":"8","author":"AK O\u2019Sullivan","year":"2005","unstructured":"O\u2019Sullivan AK, Thompson D, Drummond M. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value Health. 2005;8(1):67\u201379.","journal-title":"Value Health."},{"issue":"10","key":"1640_CR16","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.jvir.2023.06.015","volume":"34","author":"AM Pouget","year":"2023","unstructured":"Pouget AM, Costa N, Mouni\u00e9 M, Gombault-Datzenko E, Derumeaux H, Pag\u00e8s A, et al. Mechanical thrombectomy with intravenous thrombolysis versus thrombolysis alone for the treatment of stroke: a systematic review of economic evaluations. J Vasc Interv Radiol. 2023;34(10):1749-59.e2.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"1640_CR17","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1365-2125.2012.04421.x","volume":"75","author":"Z Ademi","year":"2013","unstructured":"Ademi Z, Kim H, Zomer E, Reid CM, Hollingsworth B, Liew D. Overview of pharmacoeconomic modelling methods. Br J Clin Pharmacol. 2013;75(4):944\u201350.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"1640_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1017\/S0266462314000117","volume":"30","author":"L Standfield","year":"2014","unstructured":"Standfield L, Comans T, Scuffham P. Markov modeling and discrete event simulation in health care: a systematic comparison. Int J Technol Assess Health Care. 2014;30(2):165\u201372.","journal-title":"Int J Technol Assess Health Care"},{"key":"1640_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.569500","volume":"8","author":"A Carta","year":"2020","unstructured":"Carta A, Conversano C. On the use of Markov models in pharmacoeconomics: pros and cons and implications for policy makers. Front Public Health. 2020;8:569500.","journal-title":"Front Public Health"},{"issue":"4","key":"1640_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1524-4733.2008.00467.x","volume":"12","author":"SR Earnshaw","year":"2009","unstructured":"Earnshaw SR, Wilson M, Mauskopf J, Joshi AV. Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challenges. Value Health. 2009;12(4):507\u201320.","journal-title":"Value Health."},{"issue":"9","key":"1640_CR21","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1161\/STROKEAHA.117.017199","volume":"48","author":"LK Sevick","year":"2017","unstructured":"Sevick LK, Ghali S, Hill MD, Danthurebandara V, Lorenzetti DL, Noseworthy T, et al. Systematic review of the cost and cost-effectiveness of rapid endovascular therapy for acute ischemic stroke. Stroke. 2017;48(9):2519\u201326.","journal-title":"Stroke"},{"issue":"7","key":"1640_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00415-018-8760-8","volume":"265","author":"S Boudour","year":"2018","unstructured":"Boudour S, Barral M, Gory B, Giroudon C, Aulagner G, Schott A-M, et al. A systematic review of economic evaluations on stent-retriever thrombectomy for acute ischemic stroke. J Neurol. 2018;265(7):1511\u201320.","journal-title":"J Neurol"},{"issue":"3","key":"1640_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s11845-018-1946-3","volume":"188","author":"C Teljeur","year":"2019","unstructured":"Teljeur C, Harrington P, Glynn RW, Ryan M. Acute ischaemic stroke: a systematic review of the cost-effectiveness of emergency endovascular therapy using mechanical thrombectomy. Ir J Med Sci. 2019;188(3):751\u20139.","journal-title":"Ir J Med Sci"},{"issue":"6","key":"1640_CR24","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s00330-022-08671-0","volume":"32","author":"X Wu","year":"2022","unstructured":"Wu X, Khunte M, Gandhi D, Sanelli P, Forman HP, Malhotra A. A systematic review of cost-effectiveness analyses on endovascular thrombectomy in ischemic stroke patients. Eur Radiol. 2022;32(6):3757\u201366.","journal-title":"Eur Radiol"},{"key":"1640_CR25","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.wneu.2022.09.127","volume":"169","author":"G de Rubeis","year":"2023","unstructured":"de Rubeis G, Fabiano S, Bertaccini L, Wlderk A, Pezzella FR, Anticoli S, et al. Is mechanical thrombectomy or thrombolysis universally cost-effective? A systematic review of the literature. World Neurosurg. 2023;169:e29-39.","journal-title":"World Neurosurg."},{"key":"1640_CR26","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clin Res Ed). 2021;372:n71.","journal-title":"BMJ (Clin Res Ed)."},{"key":"1640_CR27","unstructured":"Beisel A, K\u00f6nig H-H, Dams J. Endovascular treatment for acute ischemic stroke: a methodological systematic review of health-economic decision modelling studies. PROSPERO 2025 CRD420251148065. https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251148065. Accessed 30 Jun 2026."},{"key":"1640_CR28","unstructured":"National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of Health. PubMed database. https:\/\/pubmed.ncbi.nlm.nih.gov\/. Accessed 25 Jun 2025."},{"key":"1640_CR29","unstructured":"American Economic Association. EconLit Fulltext database. https:\/\/web-1p-1ebscohost-1com-10056a08v04aa.emedien3.sub.uni-hamburg.de\/ehost\/search\/advanced?vid=1&sid=529d62eb-5fc1-4d33-abe7-24b0b6dc9218%40redis. Accessed 25 Jun 2025."},{"key":"1640_CR30","unstructured":"EBSCO Information Services. EBSCOhost. EBSCO Industries, Inc."},{"key":"1640_CR31","unstructured":"Cochrane Library. Cochrane Database of Systematic Reviews (CDSR). https:\/\/www.cochranelibrary.com\/cdsr\/reviews. Accessed 25 Jun 2025."},{"key":"1640_CR32","unstructured":"University of York. Centre for Reviews and Dissemination database. https:\/\/www.crd.york.ac.uk\/CRDWeb\/. Accessed 25 Jun 2025."},{"key":"1640_CR33","unstructured":"EndNote Team. EndNote 2025. Clarivate, Philadelphia."},{"issue":"4","key":"1640_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jval.2014.12.014","volume":"18","author":"MCP Ramos","year":"2015","unstructured":"Ramos MCP, Barton P, Jowett S, Sutton AJ. A systematic review of research guidelines in decision-analytic modeling. Value Health. 2015;18(4):512\u201329.","journal-title":"Value Health."},{"issue":"3","key":"1640_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/2396987317721865","volume":"2","author":"F de Andr\u00e9s-Nogales","year":"2017","unstructured":"de Andr\u00e9s-Nogales F, \u00c1lvarez M, de Miquel M\u00c1, Segura T, Gil A, Cardona P, et al. Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain. Eur Stroke J. 2017;2(3):272\u201384.","journal-title":"Eur Stroke J"},{"issue":"11","key":"1640_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/WNL.0000000000002439","volume":"86","author":"M Aronsson","year":"2016","unstructured":"Aronsson M, Persson J, Blomstrand C, Wester P, Levin L\u00c5. Cost-effectiveness of endovascular thrombectomy in patients with acute ischemic stroke. Neurology. 2016;86(11):1053\u20139.","journal-title":"Neurology"},{"issue":"8","key":"1640_CR37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/13696998.2018.1474746","volume":"21","author":"N Arora","year":"2018","unstructured":"Arora N, Makino K, Tilden D, Lobotesis K, Mitchell P, Gillespie J. Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective. J Med Econ. 2018;21(8):799\u2013809.","journal-title":"J Med Econ"},{"issue":"3","key":"1640_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neurol.2019.06.007","volume":"176","author":"M Barral","year":"2020","unstructured":"Barral M, Armoiry X, Boudour S, Aulagner G, Schott AM, Turjman F, et al. Cost-effectiveness of stent-retriever thrombectomy in large vessel occlusion strokes of the anterior circulation: analysis from the French societal perspective. Rev Neurol (Paris). 2020;176(3):180\u20138.","journal-title":"Rev Neurol (Paris)."},{"issue":"2","key":"1640_CR39","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1161\/STROKEAHA.120.031027","volume":"52","author":"P Candio","year":"2021","unstructured":"Candio P, Violato M, Leal J, Luengo-Fernandez R. Cost-effectiveness of mechanical thrombectomy for treatment of nonminor ischemic stroke across Europe. Stroke. 2021;52(2):664\u201373.","journal-title":"Stroke"},{"issue":"9","key":"1640_CR40","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1161\/STROKEAHA.115.009396","volume":"46","author":"J Ganesalingam","year":"2015","unstructured":"Ganesalingam J, Pizzo E, Morris S, Sunderland T, Ames D, Lobotesis K. Cost-utility analysis of mechanical thrombectomy using stent retrievers in acute ischemic stroke. Stroke. 2015;46(9):2591\u20138.","journal-title":"Stroke"},{"issue":"2","key":"1640_CR41","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ana.27119","volume":"97","author":"L Gao","year":"2024","unstructured":"Gao L, Churilov L, Johns H, Pujara D, Hassan AE, Abraham M, et al. Cost-effectiveness of endovascular thrombectomy in patients with large ischemic stroke. Ann Neurol. 2024;97(2):222\u201331.","journal-title":"Ann Neurol"},{"issue":"2","key":"1640_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000525806","volume":"52","author":"L Gao","year":"2023","unstructured":"Gao L, Moodie M, Levi C, Lin L, Cheng X, Kleinig T, et al. Modelling the long-term health outcome and costs of thrombectomy in treating stroke patients with large ischaemic core: comparison between clinical trials and real-world data. Cerebrovasc Dis. 2023;52(2):137\u201344.","journal-title":"Cerebrovasc Dis"},{"key":"1640_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/15266028231201098","author":"L Gao","year":"2023","unstructured":"Gao L, Tan E, Chen C, Kleinig T, Yan B, Cheung A, et al. Cost-effectiveness of endovascular thrombectomy in M2 occlusion stroke: real-world experience versus clinical trials. J Endovasc Ther. 2023. https:\/\/doi.org\/10.1177\/15266028231201098.","journal-title":"J Endovasc Ther"},{"issue":"4","key":"1640_CR44","first-page":"1","volume":"16","author":"Health Quality Ontario","year":"2016","unstructured":"Health Quality Ontario. Mechanical thrombectomy in patients with acute ischemic stroke: a health technology assessment. Ont Health Technol Assess Ser. 2016;16(4):1\u201379.","journal-title":"Ont Health Technol Assess Ser."},{"key":"1640_CR45","unstructured":"Health Information and Quality Authority (HIQA) Ireland. Health technology assessment of a national emergency endovascular service for mechanical thrombectomy in the management of acute ischaemic stroke. 2017."},{"issue":"8","key":"1640_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/1747493019879656","volume":"15","author":"R Heggie","year":"2020","unstructured":"Heggie R, Wu O, White P, Ford GA, Wardlaw J, Brown MM, et al. Mechanical thrombectomy in patients with acute ischemic stroke: a cost-effectiveness and value of implementation analysis. Int J Stroke. 2020;15(8):881\u201398.","journal-title":"Int J Stroke"},{"issue":"4","key":"1640_CR47","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neurol.2018.06.007","volume":"175","author":"N Kabor\u00e9","year":"2019","unstructured":"Kabor\u00e9 N, Marnat G, Rouanet F, Barreau X, Verpillot E, Menegon P, et al. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France. Rev Neurol (Paris). 2019;175(4):252\u201360.","journal-title":"Rev Neurol (Paris)"},{"issue":"9","key":"1640_CR48","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/neurintsurg-2020-016765","volume":"13","author":"M Khunte","year":"2021","unstructured":"Khunte M, Wu X, Payabvash S, Zhu C, Matouk C, Schindler J, et al. Cost-effectiveness of endovascular thrombectomy in patients with acute stroke and M2 occlusion. J Neurointerv Surg. 2021;13(9):784\u20139.","journal-title":"J Neurointerv Surg."},{"issue":"6","key":"1640_CR49","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3171\/2022.2.JNS212887","volume":"137","author":"M Khunte","year":"2022","unstructured":"Khunte M, Wu X, Avery EW, Gandhi D, Payabvash S, Matouk C, et al. Impact of collateral flow on cost-effectiveness of endovascular thrombectomy. J Neurosurg. 2022;137(6):1801\u201310.","journal-title":"J Neurosurg"},{"issue":"1","key":"1640_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/neurintsurg-2021-018375","volume":"15","author":"M Khunte","year":"2023","unstructured":"Khunte M, Wu X, Koo A, Payabvash S, Matouk C, Heit JJ, et al. Cost-effectiveness of thrombectomy in patients with minor stroke and large vessel occlusion: effect of thrombus location on cost-effectiveness and outcomes. J Neurointerv Surg. 2023;15(1):39\u201345.","journal-title":"J Neurointerv Surg"},{"issue":"7","key":"1640_CR51","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1161\/STROKEAHA.110.606889","volume":"42","author":"AS Kim","year":"2011","unstructured":"Kim AS, Nguyen-Huynh M, Johnston SC. A cost-utility analysis of mechanical thrombectomy as an adjunct to intravenous tissue-type plasminogen activator for acute large-vessel ischemic stroke. Stroke. 2011;42(7):2013\u20138.","journal-title":"Stroke"},{"issue":"11","key":"1640_CR52","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1161\/STROKEAHA.116.014147","volume":"47","author":"WG Kunz","year":"2016","unstructured":"Kunz WG, Hunink MG, Sommer WH, Beyer SE, Meinel FG, Dorn F, et al. Cost-effectiveness of endovascular stroke therapy: a patient subgroup analysis from a US healthcare perspective. Stroke. 2016;47(11):2797\u2013804.","journal-title":"Stroke"},{"issue":"7","key":"1640_CR53","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1161\/STROKEAHA.115.009779","volume":"46","author":"MH Leppert","year":"2015","unstructured":"Leppert MH, Campbell JD, Simpson JR, Burke JF. Cost-effectiveness of intra-arterial treatment as an adjunct to intravenous tissue-type plasminogen activator for acute ischemic stroke. Stroke. 2015;46(7):1870\u20136.","journal-title":"Stroke"},{"issue":"8","key":"1640_CR54","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/13696998.2016.1174868","volume":"19","author":"K Lobotesis","year":"2016","unstructured":"Lobotesis K, Veltkamp R, Carpenter IH, Claxton LM, Saver JL, Hodgson R. Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK. J Med Econ. 2016;19(8):785\u201394.","journal-title":"J Med Econ"},{"issue":"8","key":"1640_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106595","volume":"31","author":"P Lylyk","year":"2022","unstructured":"Lylyk P, Cirio J, Toranzo C, Aiello E, Valencia J, Paredes-Fern\u00e1ndez D. Mechanical thrombectomy for acute ischemic stroke due to large vessel occlusion in Argentina: an economic analysis. J Stroke Cerebrovasc Dis. 2022;31(8):106595.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"1640_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/23969873231209616","volume":"9","author":"D Mehrens","year":"2024","unstructured":"Mehrens D, Fabritius MP, Reidler P, Liebig T, Afat S, Ospel JM, et al. Cost-effectiveness of endovascular treatment versus best medical management in basilar artery occlusion stroke: a U.S. healthcare perspective. Eur Stroke J. 2024;9(1):97\u2013104.","journal-title":"Eur Stroke J"},{"issue":"7","key":"1640_CR57","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jnis-2022-019849","volume":"15","author":"M Moreu","year":"2023","unstructured":"Moreu M, Scarica R, P\u00e9rez-Garc\u00eda C, Rosati S, L\u00f3pez-Fr\u00edas A, Egido JA, et al. Mechanical thrombectomy is cost-effective versus medical management alone around Europe in patients with low ASPECTS. J Neurointerv Surg. 2023;15(7):629\u201333.","journal-title":"J Neurointerv Surg."},{"issue":"1","key":"1640_CR58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13760-021-01810-2","volume":"122","author":"E Nivelle","year":"2022","unstructured":"Nivelle E, Dewilde S, Peeters A, Vanhooren G, Thijs V. Thrombectomy is a cost-saving procedure up to 24 h after onset. Acta Neurol Belg. 2022;122(1):163\u201371.","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"1640_CR59","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.223320","volume":"309","author":"JM Ospel","year":"2023","unstructured":"Ospel JM, Kunz WG, McDonough RV, Goyal M, Uchida K, Sakai N, et al. Cost-effectiveness of endovascular treatment for acute stroke with large lnfarct: a United States perspective. Radiology. 2023;309(1):e223320.","journal-title":"Radiology"},{"issue":"1","key":"1640_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1161\/STROKEAHA.121.038407","volume":"54","author":"JM Ospel","year":"2023","unstructured":"Ospel JM, Kunz WG, McDonough RV, van Zwam W, Pinckaers F, Saver JL, et al. Cost-effectiveness of endovascular treatment in large vessel occlusion stroke with mild prestroke disability: results from the HERMES collaboration. Stroke. 2023;54(1):226\u201333.","journal-title":"Stroke"},{"issue":"6","key":"1640_CR61","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1017\/cjn.2024.19","volume":"51","author":"JM Ospel","year":"2024","unstructured":"Ospel JM, Zerna C, Harrison E, Kleinig TJ, Puetz V, Kaiser DPO, et al. Cost-effectiveness of late endovascular thrombectomy vs. best medical management in a clinical trial setting and real-world setting. Can J Neurol Sci. 2024;51(6):803\u201310.","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"1640_CR62","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018951","volume":"8","author":"Y Pan","year":"2018","unstructured":"Pan Y, Cai X, Huo X, Zhao X, Liu L, Wang Y, et al. Cost-effectiveness of mechanical thrombectomy within 6 hours of acute ischaemic stroke in China. BMJ Open. 2018;8(2):e018951.","journal-title":"BMJ Open"},{"issue":"5","key":"1640_CR63","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/jnis-2023-020466","volume":"16","author":"Y Pan","year":"2024","unstructured":"Pan Y, Huo X, Jin A, Nguyen TN, Ma G, Tong X, et al. Cost-effectiveness of endovascular therapy for acute ischemic stroke with large infarct in China. J Neurointerv Surg. 2024;16(5):453\u20138.","journal-title":"J Neurointerv Surg."},{"issue":"3","key":"1640_CR64","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3171\/2008.8.JNS08133","volume":"110","author":"CG Patil","year":"2009","unstructured":"Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg. 2009;110(3):508\u201313.","journal-title":"J Neurosurg"},{"issue":"8","key":"1640_CR65","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12476","volume":"3","author":"AC Peultier","year":"2020","unstructured":"Peultier AC, Pandya A, Sharma R, Severens JL, Redekop WK. Cost-effectiveness of mechanical thrombectomy more than 6 hours after symptom onset among patients with acute ischemic stroke. JAMA Netw Open. 2020;3(8):e2012476.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1640_CR66","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/23969873231220464","volume":"9","author":"FM Pinckaers","year":"2024","unstructured":"Pinckaers FM, Evers SM, Olthuis SG, Boogaarts HD, Postma AA, van Oostenbrugge RJ, et al. Cost-effectiveness of endovascular treatment after 6\u201324 h in ischaemic stroke patients with collateral flow on CT-angiography: a model-based economic evaluation of the MR CLEAN-LATE trial. Eur Stroke J. 2024;9(2):348\u201355.","journal-title":"Eur Stroke J"},{"issue":"1","key":"1640_CR67","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1747493019830587","volume":"15","author":"E Pizzo","year":"2020","unstructured":"Pizzo E, Dumba M, Lobotesis K. Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke. Int J Stroke. 2020;15(1):75\u201384.","journal-title":"Int J Stroke"},{"issue":"9","key":"1640_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-064403","volume":"12","author":"W Rattanavipapong","year":"2022","unstructured":"Rattanavipapong W, Worakijthamrongchai T, Soboon B, Luankongsomchit V, Kongmuangpuk M, Isaranuwatchai W, et al. Economic evaluation of endovascular treatment for acute ischaemic stroke in Thailand. BMJ Open. 2022;12(9):e064403.","journal-title":"BMJ Open"},{"issue":"9","key":"1640_CR69","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/13696998.2018.1484748","volume":"21","author":"M Ruggeri","year":"2018","unstructured":"Ruggeri M, Basile M, Zini A, Mangiafico S, Agostoni EC, Lobotesis K, et al. Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy. J Med Econ. 2018;21(9):902\u201311.","journal-title":"J Med Econ"},{"issue":"e2","key":"1640_CR70","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1136\/jnis-2022-019460","volume":"15","author":"MX Sanmartin","year":"2023","unstructured":"Sanmartin MX, Katz JM, Wang J, Malhotra A, Sangha K, Bastani M, et al. Cost-effectiveness of endovascular thrombectomy in acute stroke patients with large ischemic core. J Neurointerv Surg. 2023;15(e2):e166\u201371.","journal-title":"J Neurointerv Surg."},{"issue":"10","key":"1640_CR71","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/neurintsurg-2020-016766","volume":"13","author":"A Sarraj","year":"2021","unstructured":"Sarraj A, Pizzo E, Lobotesis K, Grotta JC, Hassan AE, Abraham MG, et al. Endovascular thrombectomy in patients with large core ischemic stroke: a cost-effectiveness analysis from the SELECT study. J Neurointerv Surg. 2021;13(10):875\u201382.","journal-title":"J Neurointerv Surg."},{"key":"1640_CR72","doi-asserted-by":"publisher","first-page":"1324074","DOI":"10.3389\/fneur.2024.1324074","volume":"15","author":"J Schwarting","year":"2024","unstructured":"Schwarting J, Froelich MF, Kirschke JS, Mehrens D, Bodden J, Sepp D, et al. Endovascular thrombectomy is cost-saving in patients with acute ischemic stroke with large infarct. Front Neurol. 2024;15:1324074.","journal-title":"Front Neurol"},{"key":"1640_CR73","doi-asserted-by":"publisher","first-page":"1185304","DOI":"10.3389\/fneur.2023.1185304","volume":"14","author":"J Schwarting","year":"2023","unstructured":"Schwarting J, R\u00fchling S, Bodden J, Schwarting SK, Zimmer C, Mehrens D, et al. Endovascular thrombectomy is cost-effective in acute basilar artery occlusion stroke. Front Neurol. 2023;14:1185304.","journal-title":"Front Neurol"},{"issue":"6","key":"1640_CR74","first-page":"791","volume":"48","author":"LK Sevick","year":"2021","unstructured":"Sevick LK, Demchuk AM, Shuaib A, Smith EE, Rempel JL, Butcher K, et al. A prospective economic evaluation of rapid endovascular therapy for acute ischemic stroke. Can J Neurol Sci. 2021;48(6):791\u20138.","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"1640_CR75","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1177\/17474930211055932","volume":"17","author":"AC de Souza","year":"2022","unstructured":"de Souza AC, Martins SO, Polanczyk CA, Ara\u00fajo DV, Etges APB, Zanotto BS, et al. Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke in Brazil: results from the RESILIENT trial. Int J Stroke. 2022;17(8):855\u201362.","journal-title":"Int J Stroke"},{"issue":"8","key":"1640_CR76","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/1747493017701154","volume":"12","author":"K Steen Carlsson","year":"2017","unstructured":"Steen Carlsson K, Andsberg G, Petersson J, Norrving B. Long-term cost-effectiveness of thrombectomy for acute ischaemic stroke in real life: an analysis based on data from the Swedish Stroke Register (Riksstroke). Int J Stroke. 2017;12(8):802\u201314.","journal-title":"Int J Stroke"},{"key":"1640_CR77","doi-asserted-by":"publisher","first-page":"1267554","DOI":"10.3389\/fneur.2023.1267554","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Yu Y, Zhou L, Xu P, Guo X, Xie Y, et al. Endovascular treatment for basilar artery occlusion: a cost-effectiveness analysis based on a meta-analysis. Front Neurol. 2023;14:1267554.","journal-title":"Front Neurol"},{"issue":"6","key":"1640_CR78","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3171\/2020.9.JNS202965","volume":"135","author":"X Wu","year":"2021","unstructured":"Wu X, Payabvash S, Matouk CC, Lev MH, Wintermark M, Sanelli P, et al. Cost-effectiveness of endovascular thrombectomy in patients with low Alberta Stroke Program Early CT Scores (< 6) at presentation. J Neurosurg. 2021;135(6):1645\u201355.","journal-title":"J Neurosurg"},{"issue":"11","key":"1640_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294929","volume":"18","author":"H Xia","year":"2023","unstructured":"Xia H, Yang Q, Wang Q, Jia J, Liu X, Meng S. Economic evaluation of stent retrievers in basilar artery occlusion: an analysis from Chinese healthcare system perspective. PLoS ONE. 2023;18(11):e0294929.","journal-title":"PLoS ONE"},{"issue":"2","key":"1640_CR80","doi-asserted-by":"publisher","first-page":"E316","DOI":"10.9778\/cmajo.20150088","volume":"4","author":"X Xie","year":"2016","unstructured":"Xie X, Lambrinos A, Chan B, Dhalla IA, Krings T, Casaubon LK, et al. Mechanical thrombectomy in patients with acute ischemic stroke: a cost-utility analysis. CMAJ Open. 2016;4(2):E316\u201325.","journal-title":"CMAJ Open"},{"issue":"7","key":"1640_CR81","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/jnis-2024-021837","volume":"17","author":"S Gottschalk","year":"2025","unstructured":"Gottschalk S, K\u00f6nig HH, Subtil F, Bonekamp S, Denis A, Aamodt AH, et al. Cost-effectiveness of endovascular thrombectomy for acute ischemic stroke with established large infarct in Germany: a decision tree and Markov model. J Neurointerv Surg. 2025;17(7):683\u201390.","journal-title":"J Neurointerv Surg."},{"key":"1640_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.780894","volume":"12","author":"L Gao","year":"2021","unstructured":"Gao L, Bivard A, Parsons M, Spratt NJ, Levi C, Butcher K, et al. Real-world cost-effectiveness of late time window thrombectomy for patients with ischemic stroke. Front Neurol. 2021;12:780894.","journal-title":"Front Neurol"},{"key":"1640_CR83","unstructured":"World Bank. List of countries sorted by income. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups. Accessed 3 Sep 2025."},{"issue":"11","key":"1640_CR84","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","volume":"372","author":"M Goyal","year":"2015","unstructured":"Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019\u201330. https:\/\/doi.org\/10.1056\/NEJMoa1414905.","journal-title":"N Engl J Med"},{"issue":"24","key":"1640_CR85","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver JL, Goyal M, Bonafe A, Diener H-C, Levy EI, Pereira VM, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285\u201395.","journal-title":"N Engl J Med"},{"issue":"1","key":"1640_CR86","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"24","key":"1640_CR87","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","volume":"372","author":"TG Jovin","year":"2015","unstructured":"Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296\u2013306.","journal-title":"N Engl J Med"},{"issue":"11","key":"1640_CR88","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BC Campbell","year":"2015","unstructured":"Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009\u201318.","journal-title":"N Engl J Med"},{"issue":"6","key":"1640_CR89","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/STROKEAHA.114.005060","volume":"45","author":"J Pennlert","year":"2014","unstructured":"Pennlert J, Eriksson M, Carlberg B, Wiklund P-G. Long-term risk and predictors of recurrent stroke beyond the acute phase. Stroke. 2014;45(6):1839\u201341.","journal-title":"Stroke"},{"issue":"9499","key":"1640_CR90","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(05)67702-1","volume":"366","author":"PM Rothwell","year":"2005","unstructured":"Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366(9499):1773\u201383.","journal-title":"Lancet"},{"issue":"8","key":"1640_CR91","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1161\/STROKEAHA.114.008547","volume":"46","author":"N Chaisinanunkul","year":"2015","unstructured":"Chaisinanunkul N, Adeoye O, Lewis RJ, Grotta JC, Broderick J, Jovin TG, et al. Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin Scale. Stroke. 2015;46(8):2238\u201343.","journal-title":"Stroke"},{"issue":"3","key":"1640_CR92","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/0272989X09349961","volume":"30","author":"O Rivero-Arias","year":"2010","unstructured":"Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R. Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome. Med Decis Making. 2010;30(3):341\u201354.","journal-title":"Med Decis Making"},{"issue":"12","key":"1640_CR93","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1161\/STROKEAHA.109.561365","volume":"40","author":"K-S Hong","year":"2009","unstructured":"Hong K-S, Saver JL. Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke. 2009;40(12):3828\u201333.","journal-title":"Stroke"},{"issue":"5","key":"1640_CR94","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1177\/0272989X12454579","volume":"32","author":"DM Eddy","year":"2012","unstructured":"Eddy DM, Hollingworth W, Caro JJ, Tsevat J, McDonald KM, Wong JB. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making. 2012;32(5):733\u201343.","journal-title":"Med Decis Making"},{"issue":"3","key":"1640_CR95","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.4103\/jfmpc.jfmpc_1431_23","volume":"13","author":"AA Nimbvikar","year":"2024","unstructured":"Nimbvikar AA, Panchawagh S, Chavan AP, Ingole JR, Pargaonkar Y, Pai R. Modified Rankin scale is a reliable tool for the rapid assessment of stroke severity and predicting disability outcomes. J Family Med Prim Care. 2024;13(3):1085\u201390.","journal-title":"J Family Med Prim Care."},{"issue":"6","key":"1640_CR96","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.005788","volume":"6","author":"A Ganesh","year":"2017","unstructured":"Ganesh A, Luengo\u2010Fernandez R, Wharton RM, Gutnikov SA, Silver LE, Mehta Z, et al. Time course of evolution of disability and cause\u2010specific mortality after ischemic stroke: implications for trial design. J Am Heart Assoc. 2017;6(6):e005788.","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"1640_CR97","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1161\/STROKEAHA.113.001584","volume":"44","author":"R Luengo-Fernandez","year":"2013","unstructured":"Luengo-Fernandez R, Paul NLM, Gray AM, Pendlebury ST, Bull LM, Welch SJV, et al. Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study. Stroke. 2013;44(10):2854\u201361.","journal-title":"Stroke"},{"key":"1640_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100651","volume":"30","author":"BP Berghout","year":"2023","unstructured":"Berghout BP, Bos D, Koudstaal PJ, Ikram MA, Ikram MK. Risk of recurrent stroke in Rotterdam between 1990 and 2020: a population-based cohort study. Lancet Reg Health Eur. 2023;30:100651.","journal-title":"Lancet Reg Health Eur."},{"issue":"3","key":"1640_CR99","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/0272989X18754513","volume":"38","author":"EM Krijkamp","year":"2018","unstructured":"Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P. Microsimulation modeling for health decision sciences using R: a tutorial. Med Decis Making. 2018;38(3):400\u201322.","journal-title":"Med Decis Making"},{"issue":"6","key":"1640_CR100","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2012.06.014","volume":"15","author":"U Siebert","year":"2012","unstructured":"Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, et al. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force\u20133. Value Health. 2012;15(6):812\u201320.","journal-title":"Value Health."},{"issue":"1","key":"1640_CR101","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MLR.0000000000001417","volume":"59","author":"JM van Dongen","year":"2021","unstructured":"van Dongen JM, Jornada Ben \u00c2, Finch AP, Rossenaar MMM, Biesheuvel-Leliefeld KEM, Apeldoorn AT, et al. Assessing the impact of EQ-5D country-specific value sets on cost-utility outcomes. Med Care. 2021;59(1):82\u201390.","journal-title":"Med Care"},{"issue":"6","key":"1640_CR102","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40258-021-00664-2","volume":"19","author":"ECF Wilson","year":"2021","unstructured":"Wilson ECF. Methodological note: reporting deterministic versus probabilistic results of Markov, partitioned survival and other non-linear models. Appl Health Econ Health Policy. 2021;19(6):789\u201395.","journal-title":"Appl Health Econ Health Policy"},{"key":"1640_CR103","unstructured":"Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies. 4th ed."},{"issue":"1","key":"1640_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40273-020-00979-3","volume":"39","author":"RA Vreman","year":"2021","unstructured":"Vreman RA, Geenen JW, Knies S, Mantel-Teeuwisse AK, Leufkens HGM, Goettsch WG. The application and implications of novel deterministic sensitivity analysis methods. Pharmacoeconomics. 2021;39(1):1\u201317.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"1640_CR105","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jval.2011.12.008","volume":"15","author":"K Naver\u0161nik","year":"2012","unstructured":"Naver\u0161nik K, Rojnik K. Handling input correlations in pharmacoeconomic models. Value Health. 2012;15(3):540\u20139.","journal-title":"Value Health."},{"issue":"3","key":"1640_CR106","doi-asserted-by":"publisher","first-page":"A123","DOI":"10.1016\/j.jval.2011.02.682","volume":"14","author":"RB McQueen","year":"2011","unstructured":"McQueen RB, Libby A, Campbell J. PIN53 comparison of evidence-based variation and constant percentage variation for one-way sensitivity analyses. Value Health. 2011;14(3):A123.","journal-title":"Value Health."},{"issue":"2","key":"1640_CR107","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034463","volume":"10","author":"F Catal\u00e1-L\u00f3pez","year":"2020","unstructured":"Catal\u00e1-L\u00f3pez F, Caulley L, Ridao M, Hutton B, Husereau D, Drummond MF, et al. Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis. BMJ Open. 2020;10(2):e034463.","journal-title":"BMJ Open"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40273-026-01640-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40273-026-01640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:04:24Z","timestamp":1790348664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40273-026-01640-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":107,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1640"],"URL":"https:\/\/doi.org\/10.1007\/s40273-026-01640-1","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Judith Dams is a member of the Editorial Board of\n                      PharmacoEconomics\n                      . Judith Dams and Hans-Helmut K\u00f6nig are also co\u2011authors of one of the articles [\n                      \n                      ] analyzed in this review. Andreas Beisel has no conflicts of interest that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AB, JD, and HHK contributed to the research design. AB and JD completed the screening. Data extraction and quality assessment were completed by AB and corrected by JD. AB wrote the first draft of the manuscript, JD and HHK corrected the manuscript. All listed authors read, critically reviewed, and approved the final manuscript.","order":7,"name":"Ethics","label":"Authors\u2019 Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DeepL (\n                      \n                      ) was used for improving translations. UHH-GPT (\n                      \n                      ) was used to support grammatical corrections of the text. Chat-GPT (\n                      \n                      ) was used to support formatting and corrections of the tables.","order":8,"name":"Ethics","label":"Additional Software Used","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that this manuscript provides an honest, accurate, and transparent account of the reported study and that no important aspects have been omitted.","order":9,"name":"Ethics","label":"Transparency","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study team will actively disseminate the findings to relevant patient and public communities.","order":10,"name":"Ethics","label":"Dissemination to Participants and Related Patient and Public Communities","group":{"name":"EthicsHeading","label":"Declarations"}}]}}